Researcher Profile

Researcher Profile

Vladimir Spiegelman, MD, PhD

Vladimir Spiegelman, MD, PhD

Professor and Penn State IFC/Panhellenic Dance Marathon Chair for Pediatric Cancer Research, Department of Pediatrics
Division of Hematology and Oncology
Professor, Department of Pharmacology
Scientific Program:Mechanisms of Carcinogenesis

Research Interests

  • Messenger RNA
  • Neoplasms
  • Melanoma
  • Carrier Proteins
  • Growth
  • Catenins
  • Ubiquitin-Protein Ligases
  • Genes
  • Proteins
  • Carcinogenesis
  • Skin
  • Colorectal Neoplasms

Recent Publications


Liu, Z, Grant, CN, Sun, L, Miller, BA, Spiegelman, VS & Wang, HG 2020, 'Expression patterns of immune genes reveal heterogeneous subtypes of high-risk neuroblastoma', Cancers, vol. 12, no. 7, 1739, pp. 1-16.
Song, C, Ge, Z, Ding, Y, Tan, BH, Desai, D, Gowda, K, Amin, S, Gowda, R, Robertson, GP, Yue, F, Huang, S, Spiegelman, V, Payne, JL, Reeves, ME, Gurel, Z, Iyer, S, Dhanyamraju, PK, Xiang, M, Kawasawa, YI, Cury, NM, Yunes, JA, McGrath, M, Schramm, J, Su, R, Yang, Y, Zhao, Z, Lyu, X, Muschen, M, Payne, KJ, Gowda, C & Dovat, S 2020, 'IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia', Blood, vol. 136, no. 13, pp. 1520-1534.
Singh, V, Gowda, CP, Singh, V, Ganapathy, AS, Karamchandani, DM, Eshelman, MA, Yochum, GS, Nighot, P & Spiegelman, VS 2020, 'The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating Occludin expression', Journal of Biological Chemistry, vol. 295, no. 25.


Elcheva, I, Sneed, M, Frazee, S, Liu, Z, Zhu, J, Wood, T, Hendrickson, S, Oehler, C, Garcia, B & Spiegelman, VS 2019, 'A novel hiPSC-derived system for hematoendothelial and myeloid blood toxicity screens identifies compounds promoting and inhibiting endothelial-to-hematopoietic transition', Toxicology in Vitro, vol. 61, 104622.
Ghoshal, A, Rodrigues, LC, Gowda, CP, Elcheva, IA, Liu, Z, Abraham, T & Spiegelman, VS 2019, 'Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis', Oncogene, vol. 38, no. 21, pp. 4182-4196.
Disano, JA, Huffnagle, I, Gowda, R, Spiegelman, VS, Robertson, GP & Pameijer, CR 2019, 'Loss of miR-155 upregulates WEE1 in metastatic melanoma', Melanoma Research, vol. 29, no. 2, pp. 216-219.
Elcheva, IA, Wood, T, Chiarolanzio, K, Chim, B, Wong, M, Singh, V, Gowda, CP, Lu, Q, Hafner, M, Dovat, S, Liu, Z, Muljo, SA & Spiegelman, VS 2020, 'RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1', Leukemia, vol. 34, no. 5, pp. 1354-1363.


Noubissi, FK, Yedjou, CG, Spiegelman, VS & Tchounwou, PB 2018, 'Cross-talk between Wnt and Hh signaling pathways in the pathology of basal cell carcinoma', International journal of environmental research and public health, vol. 15, no. 7, 1442.
Chamcheu, JC, Rady, I, Chamcheu, RCN, Siddique, AB, Bloch, MB, Mbeumi, SB, Babatunde, AS, Uddin, MB, Noubissi, FK, Jurutka, PW, Liu, YY, Spiegelman, VS, Whitfield, GK & El Sayed, KA 2018, 'Graviola (Annona muricata) exerts anti-proliferative, anti-clonogenic and pro-apoptotic effects in human non-melanoma skin cancer UW-BCC1 and A431 cells in vitro: Involvement of hedgehog signaling', International journal of molecular sciences, vol. 19, no. 6, 1791.
Kim, TW, Havighurst, T, Kim, KM, Albertini, M, Xu, YG & Spiegelman, VS 2018, 'Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors', Molecular Carcinogenesis, vol. 57, no. 5, pp. 678-683.
Poenitzsch Strong, AM, Berry, SM, Beebe, DJ, Li, JL & Spiegelman, V 2018, 'miFAST: A novel and rapid microRNA target capture method', Molecular Carcinogenesis, vol. 57, no. 4, pp. 559-566.


Spiegelman, VS & Elcheva, IA 2017, 'Metabo-miR: miR-211 Regulates Mitochondrial Energy Metabolism in Vitiligo', Journal of Investigative Dermatology, vol. 137, no. 9, pp. 1828-1830.
Kim, TW, Havighurst, T, Kim, KM, Hebbring, SJ, Ye, Z, Aylward, J, Keles, S, Xu, YG & Spiegelman, VS 2017, 'RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma', Journal of Investigative Dermatology, vol. 137, no. 3, pp. 772-775.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)